Linked Life Data

18619701

Source:http://linkedlifedata.com/resource/pubmed/id/18619701

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-9-8
pubmed:abstractText
Certain host genetic polymorphisms reportedly affect the likelihood of a sustained virological response (SVR) to interferon treatment in subjects infected with hepatitis C virus (HCV). As part of the HALT-C trial we evaluated genetic associations among patients infected with HCV genotype 1 who had failed previous interferon treatment.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00042, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00043, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00051, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00065, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00633, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00827, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-01066, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-06192, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
548-56
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18619701-Adult, pubmed-meshheading:18619701-Antiviral Agents, pubmed-meshheading:18619701-Drug Therapy, Combination, pubmed-meshheading:18619701-European Continental Ancestry Group, pubmed-meshheading:18619701-Female, pubmed-meshheading:18619701-Genotype, pubmed-meshheading:18619701-Haplotypes, pubmed-meshheading:18619701-Hepacivirus, pubmed-meshheading:18619701-Hepatitis C, pubmed-meshheading:18619701-Humans, pubmed-meshheading:18619701-Interferon-alpha, pubmed-meshheading:18619701-Interleukin-10, pubmed-meshheading:18619701-Male, pubmed-meshheading:18619701-Middle Aged, pubmed-meshheading:18619701-Polyethylene Glycols, pubmed-meshheading:18619701-Polymorphism, Single Nucleotide, pubmed-meshheading:18619701-Predictive Value of Tests, pubmed-meshheading:18619701-Recombinant Proteins, pubmed-meshheading:18619701-Ribavirin, pubmed-meshheading:18619701-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.
pubmed:affiliation
Division of Gastroenterology, University of California Irvine, Irvine, CA, USA. timothy.morgan@va.gov
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural